Recombinant Human Thymosin Beta 4 Injection (NL005) for anterior wall myocardial infarction

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 14 May 2026: Trial registered, NCT07586865

The trials

NCT07586865: Recombinant Human Thymosin Beta 4 for Injection(NL005) for Acute Myocardial Infarction

State
Not started
Phase
Phase 2
People
189 planned
Started
18 May 2026
Primary completion
17 Aug 2027
Arms
NL005 10 µg/kg Group, NL005 20 µg/kg Group
Results
None posted
  1. 14 May 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.